Ivision Tech S.P.A.
MMIL:IVN1.26
EUR
-0.08
(-5.97%)
ISIN
IT0005554784
Return %
Stock
S&P 500
1Y
-42.73
14.20
3Y
-1.56
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Martignacco Italy
- IPO Date
- Aug 1, 2023
- Website
- ivisiontech.eu
- Similar Companies
- Business
- Ivision Tech S.p.A. is an Italy-based manufacturing company specializing in the design, engineering, and industrial production of high-end optical frames, sunglasses, and assistive wearable eyewear solutions for international luxury fashion houses and independent optical brands. The company operates across integrated manufacturing and technology divisions, providing comprehensive original design manufacturing (ODM) and original equipment manufacturing (OEM) services. Its primary product and service portfolio comprises the design, prototyping, tooling, and mass fabrication of luxury acetate, metal, and injection-molded spectacle frames; precision mechanical processing, tumbling, manual polishing, and surface finishing; the assembly, laser engraving, pad printing, and regulatory testing of complete optical and sunglass collections; the manufacturing of heritage luxury eyewear under the historic French brand Maison Henry Jullien, renowned for patented Doublé Or rolled-gold wire craftsmanship; the production, finishing, and anti-reflective treatment of ophthalmic and sun lenses; and the development of proprietary assistive smart glasses, including the SeeMe electronic mobility device equipped with sensor and artificial intelligence technologies to assist visually impaired individuals with obstacle detection and spatial navigation. Headquartered in Martignacco, Udine, Italy, and founded in 2020, the company serves luxury brand owners, optical wholesalers, and healthcare distribution channels across Europe, the Americas, and Asia, supported by production and research facilities in Italy, France, and Bulgaria. In recent developments, Ivision Tech completed its initial public offering on the Euronext Growth Milan exchange in August 2023 to support industrial growth, technological innovation, and cross-border expansion. Strategically enhancing its luxury portfolio, the company acquired a controlling 60% stake in French luxury eyewear maker Maison Henry Jullien, integrating its artisanal manufacturing site in the Jura region. The company further expanded its vertical integration through the acquisition and consolidation of Bulgarian ophthalmic lens manufacturer Ivilens OOD, allowing internal production and coating of prescription lenses. In addition, Ivision Tech has accelerated the commercial rollout and international clinical partnerships for its proprietary smart eyewear division, broadening its distribution agreements across European medical and specialized optical networks.